Xtandi Europäische Union - Deutsch - EMA (European Medicines Agency)

xtandi

astellas pharma europe b.v. - enzalutamid - prostata-neoplasmen - endokrine therapie - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.

Xtandi 40 mg Filmtabletten Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

xtandi 40 mg filmtabletten

astellas pharma ag - enzalutamidum - filmtabletten - enzalutamidum 40 mg, hypromellosi acetas succinas, cellulosum microcristallinum, silica colloidalis anhydrica, carmellosum natricum conexum corresp. natrium max. 3 mg, magnesii stearas, Überzug: hypromellosum, talcum, macrogolum 8000, e 171, e 172 (flavum), pro compresso obducto. - prostatakarzinom - synthetika

Xtandi 80 mg Filmtabletten Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

xtandi 80 mg filmtabletten

astellas pharma ag - enzalutamidum - filmtabletten - enzalutamidum 80 mg, hypromellosi acetas succinas, cellulosum microcristallinum, silica colloidalis anhydrica, carmellosum natricum conexum corresp. natrium max. 6 mg, magnesii stearas, Überzug: hypromellosum, talcum, macrogolum 8000, e 171, e 172 (flavum), pro compresso obducto. - prostatakarzinom - synthetika

Xtandi 40 mg Weichkapseln Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

xtandi 40 mg weichkapseln

astellas pharma ag - enzalutamidum - weichkapseln - enzalutamidum 40 mg, antiox.: e 320, e 321, excipiens für die kapsel. - prostatakarzinom - synthetika